These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36084045)

  • 1. Desformylflustrabromine (dFBr), a positive allosteric modulator of α4β2 nicotinic acetylcholine receptors decreases voluntary ethanol consumption and preference in male and female Sprague-Dawley rats.
    Decker S; Davis G; Vahora I; Vukovic A; Patel P; Suryanarayanan A
    PLoS One; 2022; 17(9):e0273715. PubMed ID: 36084045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric modulation of α4β2* nicotinic acetylcholine receptors: Desformylflustrabromine potentiates antiallodynic response of nicotine in a mouse model of neuropathic pain.
    Bagdas D; Ergun D; Jackson A; Toma W; Schulte MK; Damaj MI
    Eur J Pain; 2018 Jan; 22(1):84-93. PubMed ID: 28809075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desformylflustrabromine (dFBr), a positive allosteric modulator of the α
    DeCristofano L; Decker S; Schulte MK; Suryanarayanan A
    Alcohol; 2021 Jun; 93():35-44. PubMed ID: 33652092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration.
    Liu X
    Psychopharmacology (Berl); 2013 Nov; 230(2):203-13. PubMed ID: 23712602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of (α4)2(β2)3, but not (α4)3(β2)2, nicotinic acetylcholine receptors reduces nicotine self-administration and withdrawal symptoms.
    Hamouda AK; Bautista MR; Akinola LS; Alkhlaif Y; Jackson A; Carper M; Toma WB; Garai S; Chen YC; Thakur GA; Fowler CD; Damaj MI
    Neuropharmacology; 2021 Jun; 190():108568. PubMed ID: 33878302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desformylflustrabromine, a positive allosteric modulator of α4β2-containing nicotinic acetylcholine receptors, enhances cognition in rats.
    Nikiforuk A; Litwa E; Krawczyk M; Popik P; Arias H
    Pharmacol Rep; 2020 Jun; 72(3):589-599. PubMed ID: 32207091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of Nicotine Withdrawal Signs Through Positive Allosteric Modulation of α4β2 Nicotinic Acetylcholine Receptors in Male Mice.
    Hamouda AK; Jackson A; Bagdas D; Imad Damaj M
    Nicotine Tob Res; 2018 Jun; 20(7):903-907. PubMed ID: 29059422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of the allosteric modulator desformylflustrabromine and its interaction with alpha4beta2 neuronal nicotinic acetylcholine receptor orthosteric ligands.
    Weltzin MM; Schulte MK
    J Pharmacol Exp Ther; 2010 Sep; 334(3):917-26. PubMed ID: 20516140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the Effects of (α4)3(β2)2 Nicotinic Acetylcholine Receptor-Selective Positive Allosteric Modulator on Acute Thermal Nociception in Rats.
    Deba F; Ramos K; Vannoy M; Munoz K; Akinola LS; Damaj MI; Hamouda AK
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32630476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric modulator Desformylflustrabromine relieves the inhibition of α2β2 and α4β2 nicotinic acetylcholine receptors by β-amyloid(1-42) peptide.
    Pandya A; Yakel JL
    J Mol Neurosci; 2011 Sep; 45(1):42-7. PubMed ID: 21424792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of Compulsive-Like Behavior Through Positive Allosteric Modulation of α4β2 Nicotinic Acetylcholine Receptors in Non-Induced Compulsive-Like Mice.
    Mitra S; Mucha M; Khatri SN; Glenon R; Schulte MK; Bult-Ito A
    Front Behav Neurosci; 2016; 10():244. PubMed ID: 28105008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desformylflustrabromine Modulates α4β2 Neuronal Nicotinic Acetylcholine Receptor High- and Low-Sensitivity Isoforms at Allosteric Clefts Containing the β2 Subunit.
    Weltzin MM; Schulte MK
    J Pharmacol Exp Ther; 2015 Aug; 354(2):184-94. PubMed ID: 26025967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desformylflustrabromine (dFBr) and [3H]dFBr-Labeled Binding Sites in a Nicotinic Acetylcholine Receptor.
    Hamouda AK; Wang ZJ; Stewart DS; Jain AD; Glennon RA; Cohen JB
    Mol Pharmacol; 2015 Jul; 88(1):1-11. PubMed ID: 25870334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking.
    Steensland P; Simms JA; Holgate J; Richards JK; Bartlett SE
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12518-23. PubMed ID: 17626178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats.
    Bito-Onon JJ; Simms JA; Chatterjee S; Holgate J; Bartlett SE
    Addict Biol; 2011 Jul; 16(3):440-9. PubMed ID: 21392178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. des-Formylflustrabromine (dFBr): A Structure-Activity Study on Its Ability To Potentiate the Action of Acetylcholine at α4β2 Nicotinic Acetylcholine Receptors.
    Dukat M; Jain A; German N; Ferrara-Pontoriero R; Huang Y; Ma Y; Schulte MK; Glennon RA
    ACS Chem Neurosci; 2018 Dec; 9(12):2984-2996. PubMed ID: 30028943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nicotine in combination with drugs described as positive allosteric nicotinic acetylcholine receptor modulators in vitro: discriminative stimulus and hypothermic effects in mice.
    Moerke MJ; de Moura FB; Koek W; McMahon LR
    Eur J Pharmacol; 2016 Sep; 786():169-178. PubMed ID: 27238974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Administration of Desformylflustrabromine Relieves Chemically Induced Pain in CD-1 Mice.
    Weggel LA; Pandya AA
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30866543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of desformylflustrabromine and its evaluation as an alpha4beta2 and alpha7 nACh receptor modulator.
    Kim JS; Padnya A; Weltzin M; Edmonds BW; Schulte MK; Glennon RA
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4855-60. PubMed ID: 17604168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial agonists of the α3β4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats.
    Chatterjee S; Steensland P; Simms JA; Holgate J; Coe JW; Hurst RS; Shaffer CL; Lowe J; Rollema H; Bartlett SE
    Neuropsychopharmacology; 2011 Feb; 36(3):603-15. PubMed ID: 21048701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.